The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.

The agency is inviting public comment on a new discussion paper as it prepares to shape policy covering robotic medical ...

Edwards’ TAVR device in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation ...

CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did ...

The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts ...

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient ...

The CEO change was unexpected and prompted a stock selloff Friday, analysts said, but the new chief executive is prepared for ...

The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the ...

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also ...

M&A rose, but company valuations declined in the first half of 2026 compared with the year-ago period, according to EY’s ...

Dr. Rick Baehner, Abbott’s chief medical officer for precision oncology, spoke to MedTech Dive about how the new version of ...

Stryker said Monday it has closed its takeover of ZuriMED, adding a device for treating rotator cuff tears to its portfolio.